The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia
Knowledge on acute myeloid leukemia pathogenesis and treatment has progressed recently, but not enough to provide ideal management. Improving the prognosis of acute myeloid leukemia patients depends on advances in molecular biology for the detection of new therapeutic targets and the production of e...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Palacký University Olomouc, Faculty of Medicine and Dentistry
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/80b275a3ae6e4e0da9613e401454cc5f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|